However, the expression of LOXL1 in colorectal cancer (CRC) remains controversial, with reports suggesting both upregulation and downregulation (Ye et al., 2020; Barker, Cox & Erler, 2012) (Table 1). Here, LOXL1 is linked to colorectal cancer.